Once- versus Twice-Daily Administration of Amikacin in Pediatric Patients with Bronchopneumonia: Plasma Drug Concentration and Bayesian Pharmacokinetics Estimation
Restricted accessLetterFirst published online June, 1999
Once- versus Twice-Daily Administration of Amikacin in Pediatric Patients with Bronchopneumonia: Plasma Drug Concentration and Bayesian Pharmacokinetics Estimation
LogsdonBAPhelpsSJ. Routine monitoring of gentamicin serum concentrations in pediatric patients with normal renal function is unnecessary. Ann Pharmacother1997;31: 1514–8.
2.
ThomsonAHWhitingB. Bayesian parameter estimation and population pharmacokinetics. Clin Pharmacokinet1992;22: 447–67.
3.
SheinerLBBealSL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm1981;9: 503–12.
4.
ZaskeDEShikumaLRThollDA. Aminoglycosides. In: TaylorWJCavinessMH Diers, eds. A textbook for the clinical application of therapeutic drug monitoring. Irving, TX: Abbott Laboratories, Diagnostic Division, 1986: 285–320.
5.
HardmanJGLimbindLE, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 9th ed.New York: McGraw Hill, 1996;Appendix II:1714.
6.
ErdmanSMRodvoldKAPrykaRD. An update comparison of drug dosing methods (part III): Aminoglycoside antibiotics. Clin Pharmacokinet1991;20: 374–88.